Pancreatic

Researchers at Mayo Clinic have designed an artificial intelligence model that can potentially predict an individual’s risk of developing pancreatic cancer years before diagnosis. Research will be presented at the…

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a…